Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: aspirin / gantrisin / sulfa (sulfonamide antibiotics) attending: chief complaint: dyspnea on exertion major surgical or invasive procedure: 1. aortic valve replacement with a 25-mm st. tissue valve, reference number , serial number . 2. coronary artery bypass grafting times 1 with left internal mammary artery to left anterior descending artery. history of present illness: mr. who is an 86-year-old male with past medical history of atrial fibrillation, first and second-degree wenckebach av block, severe aortic valve stenosis, systolic congestive heart failure, presents with worsening dyspnea on exertion and need of tissue avr scheduled for presenting to ccu for aspirin desensitization. his history of aspirin "allergy" was from >40 yrs ago where he reports ?shortness of breath, but unclear if had true anaphylaxis- regardless he was told not to ever take the drug again. from an as standpoint, he was not deemed high enough surgical risk for core valve and thus given his progression of symptoms with dyspnea with minimal exertion, decision was made to proceed with avr. cardiac surgery was consulted for evaluation of aortic valve replacement. past medical history: pad status post aaa repair (endovascular ) hypertension dyslipidemia aortic stenosis paf (warfarin) coronary artery disease probable ischemic cardiomyopathy with chronic systolic heart failure and lvef of 30% gout steroid-dependent asthma mild obesity first and second-degree wenckebach av block. not on beta blockers due av block/bradycardia nephrolithiasis tuberculosis (45yrs ago - treated) ventral hernia repair rt inguinal hernia repair x 2 left wrist ganglion removal left antecubital nerve severed, s/p repair rt heel spurs repair social history: non-smoker, 2-3oz wine per day, married, 3 daughters family history: father mi age 52, brother mi age 58 physical exam: admission physical examination: vs: 97.6 46 105/55 14 99 3l general: nad. oriented x3. mood, affect appropriate. heent: ncat. sclera anicteric. perrl, eomi. conjunctiva were pink, no pallor or cyanosis of the oral mucosa. no xanthalesma. neck: lying flat for post cath and thus no jvd appreciated.. cardiac: irreg irregular ryhthm, bradycardic, 3/6 sem lsb, no s3 or thrills. lungs: cta b/l anterior lung fields. abdomen: soft, nt/nd. extremities: + edema to knees b/l neuro: aaox3, cnii-xii intact, 5/5 strength biceps pulses: dp/pt 2+ b/l . pertinent results: admission labs: 02:00pm blood wbc-7.4 rbc-3.55* hgb-10.6* hct-34.7* mcv-98# mch-29.9 mchc-30.5* rdw-16.8* plt ct-166 08:00am blood pt-11.6 inr(pt)-1.1 02:00pm blood glucose-89 urean-20 creat-0.9 na-137 k-4.2 cl-105 hco3-29 angap-7* 09:35am blood alt-14 ast-14 ck(cpk)-27* alkphos-88 totbili-0.4 dirbili-0.2 indbili-0.2 02:00pm blood calcium-9.0 phos-2.7 mg-2.1 09:35am blood vitb12-353 09:35am blood %hba1c-6.2* eag-131* 09:35am blood triglyc-111 hdl-50 chol/hd-2.5 ldlcalc-54 . imaging: . cath: final diagnosis: 1. moderate 2 vessel coronary artery disease with diffuse atherosclerosis. 2. mild pulmonary arterial hypertension. 3. reinforce secondary preventative measures against cad. 4. additional plans per dr. and . 5. would advocate asa desensitization in cvicu post-avr so that patient can be discharged on aspirin 81mg daily rather than clopidogrel. 6. f/u with dr. . . cxr: since the prior study, there is interval progression of bilateral interstitial opacities most likely representing chronic interstitial lung disease, potentially fibrosis. heart size and mediastinum are unchanged including cardiomegaly. no pleural effusion or pneumothorax is seen. the lung volumes are low. assessment of the patient with chest ct for precise characterization of the severity and extent of pulmonary abnormalities might be considered. cxr: the left lower chest tube has been removed. the left upper chest tube is still in place. there is a small left apical pneumothorax, similar in size compared to the study from the prior day. mild pulmonary vascular redistribution and volume loss in both lower lobes. sternal wires are again visualized. cxr: brief hospital course: mr. presented to ccu on for aspirin desensitization. on he was taken to the operating room and underwent the following:aortic valve replacement with a 25-mm st. tissue valve,coronary artery bypass grafting times 1 with left internal mammary artery to left anterior descending artery.cross-clamp time: 85 minutes. pump time: 98 minutes. he tolerated the procedure well and was transferred to the cvicu intubated and sedated in critical but stable condition. he was initially requiring phenylephrine with sedation. he awoke neurologically intact and was weaned to extubation early on pod#1. pressor support was weaned off and gentle diuresis begun. no beta-blockers initiated due to the patient's history of first and second degree av block. pacing wires were removed on pod#2 and he was started on coumadin for pre-op a-fib. he was transferred to the floor on pod#2 with chest tubes in place. a picc line was placed for intravenous access. on post-operative day number 3, the patient remained hemodynamically stable with paf. coumadin therapy was continued. the foley catheter was discontinued and the patient was started on cipro for a positive ua, urine culture was pending ( results showed yeast). the patient sternal incision showed a small amount of seroud drainage, and he was started on kefzol. chest tubes were discontinued on post-op day 4 without complication. decreased steranl drainaeg, the kefzol was discontinued. the urine culture only showed yeast, and the cipro was also discontinued. lopressor was discontinued for intermittent type ii heart block. continue to hold beta blockers. the patient inr is 2.2 today (), and he is hemodynamically stable. he will be dischared on lasix 80mg iv bid x 7 days for his cxr and peripheral edema. follow-up in wound clinic in one week. the picc line will remain in place upon discharge to rehabilitation, the rehab center will be advised to discontinue the picc line once the course of iv lasix is complete. it is felt that he is safe to be discharged to new rehabilitation center in on pod #5. medications on admission: allopurinol 300 mg p.o. daily lipitor 80 mg p.o. q.h.s. atacand 4 mg tablet one p.o. q.h.s. plavix 75 mg p.o. daily colchicine/probenecid combination 0.5 mg/500 mg one p.o. daily, finasteride 5 mg tablet one p.o. daily prednisone 5 mg tablet one p.o. daily with 2.5 mg tablet p.o. q.h.s. flomax 0.4 mg capsule extended release one p.o. daily torsemide 20 mg tablet one p.o. daily warfarin daily as directed ranitidine hydrochloride extended release tablet one p.o. daily. discharge medications: 1. magnesium hydroxide 400 mg/5 ml suspension sig: thirty (30) ml po daily (daily) as needed for constipation. 2. aspirin 81 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po daily (daily). 3. tamsulosin 0.4 mg capsule, ext release 24 hr sig: one (1) capsule, ext release 24 hr po hs (at bedtime). 4. finasteride 5 mg tablet sig: one (1) tablet po daily (daily). 5. probenecid 500 mg tablet sig: one (1) tablet po daily (daily). 6. atorvastatin 80 mg tablet sig: one (1) tablet po daily (daily). 7. allopurinol 300 mg tablet sig: one (1) tablet po daily (daily). 8. prednisone 5 mg tablet sig: one (1) tablet po qam (once a day (in the morning)). 9. prednisone 5 mg tablet sig: 0.5 tablet po qpm (once a day (in the evening)). 10. ranitidine hcl 150 mg tablet sig: one (1) tablet po bid (2 times a day). 11. acetaminophen 325 mg tablet sig: two (2) tablet po q6h (every 6 hours) as needed for pain. 12. lasix sig: eighty (80) mg intravenous twice a day for 7 days. 13. potassium chloride 20 meq tablet, er particles/crystals sig: two (2) tablet, er particles/crystals po twice a day for 7 days. 14. albuterol sulfate 2.5 mg /3 ml (0.083 %) solution for nebulization sig: one (1) inhalation q6h (every 6 hours) as needed for dyspnea. 15. ipratropium bromide 0.02 % solution sig: one (1) inhalation q6h (every 6 hours) as needed for dyspnea. 16. warfarin 1 mg tablet sig: one (1) tablet po once a day: please take 1mg on . check inr on and dose per inr level. discharge disposition: extended care facility: tba discharge diagnosis: primary: status post aortic valve replacement/coronary artrey bypass grafting secondary: 1. aortic stenosis 2. peripheral vascular disease. 3. status post abdominal aortic aneurysm repair (endovascular repair in at ). 4. hypertension. 5. dyslipidemia, moderate. 6. paroxysmal atrial fibrillation on warfarin. 7. coronary artery disease 8. probable ischemic cardiomyopathy with chronic systolic heart failure with left ventricular ejection fraction of 30%. 9. gout. 10. steroid-dependent asthma. 11. mild obesity. 12. first and second degree wenckebach. 13. nephrolithiasis. 14. tuberculosis (45 years ago treated with inh). 15. status post ventral hernia repair. 16. status post right inguinal hernia repair x2. 17. status post left wrist ganglion removal. 18. left antecubital nerve repair, right heel spur. discharge condition: alert and oriented x3 nonfocal ambulating with steady gait incisional pain managed with incisions: sternal - healing well, no erythema or drainage leg right/left - healing well, no erythema or drainage. edema discharge instructions: please shower daily including washing incisions gently with mild soap, no baths or swimming until cleared by surgeon. look at your incisions daily for redness or drainage please no lotions, cream, powder, or ointments to incisions each morning you should weigh yourself and then in the evening take your temperature, these should be written down on the chart no driving for approximately one month and while taking narcotics, will be discussed at follow up appointment with surgeon when you will be able to drive no lifting more than 10 pounds for 10 weeks please call with any questions or concerns females: please wear bra to reduce pulling on incision, avoid rubbing on lower edge **please call cardiac surgery office with any questions or concerns . answering service will contact on call person during off hours** recommended follow-up: you are scheduled for the following appointments surgeon: cardiologist: please call to schedule appointments with your primary care dr..... in weeks **please call cardiac surgery office with any questions or concerns . answering service will contact on call person during off hours** labs: pt/inr for coumadin ?????? indication goal inr first draw results to phone fax followup instructions: you are scheduled for the following appointments surgeon: dr. , at 10:00am for wound check surgeon: dr. , at 1:00pm cardiologist: , , # please call to schedule appointments with your primary care dr. within 1-2 weeks, # **please call cardiac surgery office with any questions or concerns . answering service will contact on call person during off hours** labs: pt/inr for coumadin ?????? indication: post-operative atrial fibrillation. goal inr 2.0 - 2.5 first draw on ***please chem 10 on to monitor renal function and potassium. procedure: venous catheterization, not elsewhere classified single internal mammary-coronary artery bypass extracorporeal circulation auxiliary to open heart surgery combined right and left heart cardiac catheterization coronary arteriography using two catheters (aorto)coronary bypass of one coronary artery open and other replacement of aortic valve with tissue graft immunization for allergy diagnoses: other iatrogenic hypotension coronary atherosclerosis of native coronary artery other postoperative infection urinary tract infection, site not specified congestive heart failure, unspecified unspecified essential hypertension long-term (current) use of steroids iron deficiency anemia secondary to blood loss (chronic) chronic airway obstruction, not elsewhere classified gout, unspecified atrial fibrillation aortic valve disorders percutaneous transluminal coronary angioplasty status other specified forms of chronic ischemic heart disease other and unspecified hyperlipidemia other specified cardiac dysrhythmias surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation osteoporosis, unspecified long-term (current) use of anticoagulants other postprocedural status obesity, unspecified chronic obstructive asthma, unspecified acute on chronic systolic heart failure atherosclerosis of native arteries of the extremities, unspecified calculus of kidney examination of participant in clinical trial other and unspecified mycoses other second degree atrioventricular block personal history of tuberculosis personal history of allergy to analgesic agent generalized and unspecified atherosclerosis 

Answer: The patient is high likely exposed to